लोड हो रहा है...
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
Targeted therapies such as kinase inhibitors and monoclonal antibodies have dramatically altered cancer care in recent decades. Although these targeted therapies have improved patient outcomes in several cancer types, resistance ultimately develops to these agents. One potential strategy proposed to...
में बचाया:
| में प्रकाशित: | Genome Med |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BioMed Central
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5399860/ https://ncbi.nlm.nih.gov/pubmed/28431544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-017-0431-3 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|